487 related articles for article (PubMed ID: 27658510)
1. Purinergic Signalling and Neurological Diseases: An Update.
Burnstock G
CNS Neurol Disord Drug Targets; 2017; 16(3):257-265. PubMed ID: 27658510
[TBL] [Abstract][Full Text] [Related]
2. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
Burnstock G
Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033
[TBL] [Abstract][Full Text] [Related]
3. Purinergic signalling: from normal behaviour to pathological brain function.
Burnstock G; Krügel U; Abbracchio MP; Illes P
Prog Neurobiol; 2011 Oct; 95(2):229-74. PubMed ID: 21907261
[TBL] [Abstract][Full Text] [Related]
4. Introduction to Purinergic Signaling.
Burnstock G
Methods Mol Biol; 2020; 2041():1-15. PubMed ID: 31646477
[TBL] [Abstract][Full Text] [Related]
5. Introduction to purinergic signalling in the brain.
Burnstock G
Adv Exp Med Biol; 2013; 986():1-12. PubMed ID: 22879061
[TBL] [Abstract][Full Text] [Related]
6. Purinergic Signalling: Therapeutic Developments.
Burnstock G
Front Pharmacol; 2017; 8():661. PubMed ID: 28993732
[TBL] [Abstract][Full Text] [Related]
7. P2X and P2Y receptors—role in the pathophysiology of the nervous system.
Puchałowicz K; Tarnowski M; Baranowska-Bosiacka I; Chlubek D; Dziedziejko V
Int J Mol Sci; 2014 Dec; 15(12):23672-704. PubMed ID: 25530618
[TBL] [Abstract][Full Text] [Related]
8. Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events.
Apolloni S; Montilli C; Finocchi P; Amadio S
FEBS J; 2009 Jan; 276(2):354-64. PubMed ID: 19076216
[TBL] [Abstract][Full Text] [Related]
9. Introduction to Purinergic Signalling in the Brain.
Burnstock G
Adv Exp Med Biol; 2020; 1202():1-12. PubMed ID: 32034706
[TBL] [Abstract][Full Text] [Related]
10. Purinergic signalling: past, present and future.
Burnstock G
Braz J Med Biol Res; 2009 Jan; 42(1):3-8. PubMed ID: 18853040
[TBL] [Abstract][Full Text] [Related]
11. Physiopathological roles of P2X receptors in the central nervous system.
Burnstock G
Curr Med Chem; 2015; 22(7):819-44. PubMed ID: 25005189
[TBL] [Abstract][Full Text] [Related]
12. Purinergic signalling and disorders of the central nervous system.
Burnstock G
Nat Rev Drug Discov; 2008 Jul; 7(7):575-90. PubMed ID: 18591979
[TBL] [Abstract][Full Text] [Related]
13. Purinergic receptors in psychiatric disorders.
Krügel U
Neuropharmacology; 2016 May; 104():212-25. PubMed ID: 26518371
[TBL] [Abstract][Full Text] [Related]
14. P2X7 receptor: an emerging target in central nervous system diseases.
Sperlágh B; Illes P
Trends Pharmacol Sci; 2014 Oct; 35(10):537-47. PubMed ID: 25223574
[TBL] [Abstract][Full Text] [Related]
15. Introductory overview of purinergic signalling.
Burnstock G
Front Biosci (Elite Ed); 2011 Jun; 3(3):896-900. PubMed ID: 21622101
[TBL] [Abstract][Full Text] [Related]
16. Purinergic signaling in Alzheimer's disease.
Erb L; Woods LT; Khalafalla MG; Weisman GA
Brain Res Bull; 2019 Sep; 151():25-37. PubMed ID: 30472151
[TBL] [Abstract][Full Text] [Related]
17. Purinergic signalling: pathophysiology and therapeutic potential.
Burnstock G
Keio J Med; 2013; 62(3):63-73. PubMed ID: 24067872
[TBL] [Abstract][Full Text] [Related]
18. The Therapeutic Potential of Purinergic Receptors in Alzheimer's Disease and Promising Therapeutic Modulators.
Pan L; Ma Y; Li Y; Wu H; Huang R; Cai Z; Wu X
Mini Rev Med Chem; 2021; 21(11):1288-1302. PubMed ID: 33302833
[TBL] [Abstract][Full Text] [Related]
19. Purinergic receptors in cognitive disturbances.
Illes P; Ulrich H; Chen JF; Tang Y
Neurobiol Dis; 2023 Sep; 185():106229. PubMed ID: 37453562
[TBL] [Abstract][Full Text] [Related]
20. Role of the purinergic signaling in epilepsy.
Cieślak M; Wojtczak A; Komoszyński M
Pharmacol Rep; 2017 Feb; 69(1):130-138. PubMed ID: 27915186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
